Perla Ivonne Gallegos-Flores

Dr. Perla Ivonne Gallegos-Flores

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2021 in Cells
Verified
Journal Article
Open access
PDF file
FMFátima Martínez-Rodríguez
Fátima Martínez-Rodríguez
JLJared E. Limones-González
Jared E. Limones-González
BMBrenda Mendoza-Almanza
Brenda Mendoza-Almanza
EIEdgar León Esparza Ibarra
Edgar León Esparza Ibarra
PGPerla Ivonne Gallegos-Flores
Perla Ivonne Gallegos-Flores
GMGretel Mendoza
Gretel Mendoza
Cancer is one of the leading public health issues worldwide, and the number of cancer patients increases every day. Particularly, cervical cancer (CC) is still the second leading cause of cancer death in women from developing countries. Thus, it is essential to deepen our knowledge about the molecular pathogenesis of CC and propose new therapeutic targets and new methods to diagnose this disease in its early stages. Differential expression analysis using high-throughput techniques applied to biological samples allows determining the physiological state of normal cells and the changes produced by cancer development. The cluster of differential molecular profiles in the genome, the transcriptome, or the proteome is analyzed in the disease, and it is called the molecular signature of cancer. Proteomic analysis of biological samples of patients with different grades of cervical intraepithelial neoplasia (CIN) and CC has served to elucidate the pathways involved in the development and progression of cancer and identify cervical proteins associated with CC. However, several cervical carcinogenesis mechanisms are still unclear. Detecting pathologies in their earliest stages can significantly improve a patient’s survival rate, prognosis, and recurrence. The present review is an update on the proteomic study of CC.

Verified
Journal Article
Open access
PDF file
EMErika Maldonado-Rodriguez
Erika Maldonado-Rodriguez
MHMarisa Hernández-Barrales
Marisa Hernández-Barrales
ARAdrián Reyes-López
Adrián Reyes-López
Susana GodinaSusana Godina
Susana Godina
PGPerla Ivonne Gallegos-Flores
Perla Ivonne Gallegos-Flores
JAJorge Luis Ayala-Luján
Jorge Luis Ayala-Luján
Breast cancer is the leading cause of cancer death among women worldwide. Multiple extrinsic and intrinsic factors are associated with this disease’s development. Various research groups worldwide have reported the presence of human papillomavirus (HPV) DNA in samples of malignant breast tumors. Although its role in mammary carcinogenesis is not fully understood, it is known that the HPV genome, once inserted into host cells, has oncogenic capabilities. The present study aimed to detect the presence of HPV DNA in 116 breast tissue biopsies and classify them according to their histology. It was found that 50.9% of the breast biopsies analyzed were malignant neoplasms, of which 74.6% were histologically classified as infiltrating ductal carcinoma. In biopsies with non-malignant breast disease, fibroadenoma was the most common benign neoplasm (39.1%). Detection of HPV DNA was performed through nested PCR using the external primer MY09/11 and the internal primer GP5+/6+. A hybridization assay genotyped HPV. HPV DNA was identified in 20.3% (12/59) of malignant neoplasms and 35% non-malignant breast disease (16/46). It was also detected in 27.3% (3/11) of breast tissue biopsies without alteration. However, there are no statistically significant differences between these groups and the existence of HPV DNA (p = 0.2521). Its presence was more frequent in non-malignant alterations than in malignant neoplasias. The most frequent genotypes in the HPV-positive samples were low-risk (LR) HPV-42 followed by high-risk (HR) HPV-31.

3 February 2022 in Membranes
Verified
Journal Article
Open access
PDF file
NDNazly Z. Durán-Saenz
Nazly Z. Durán-Saenz
ASAlejandra Serrano-Puente
Alejandra Serrano-Puente
PGPerla Ivonne Gallegos-Flores
Perla Ivonne Gallegos-Flores
BMBrenda D. Mendoza-Almanza
Brenda D. Mendoza-Almanza
EIEdgar León Esparza Ibarra
Edgar León Esparza Ibarra
GMGretel Mendoza-Almanza
Gretel Mendoza-Almanza
In addition to being biological barriers where the internalization or release of biomolecules is decided, cell membranes are contact structures between the interior and exterior of the cell. Here, the processes of cell signaling mediated by receptors, ions, hormones, cytokines, enzymes, growth factors, extracellular matrix (ECM), and vesicles begin. They triggering several responses from the cell membrane that include rearranging its components according to the immediate needs of the cell, for example, in the membrane of platelets, the formation of filopodia and lamellipodia as a tissue repair response. In cancer, the cancer cells must adapt to the new tumor microenvironment (TME) and acquire capacities in the cell membrane to transform their shape, such as in the case of epithelial−mesenchymal transition (EMT) in the metastatic process. The cancer cells must also attract allies in this challenging process, such as platelets, fibroblasts associated with cancer (CAF), stromal cells, adipocytes, and the extracellular matrix itself, which limits tumor growth. The platelets are enucleated cells with fairly interesting growth factors, proangiogenic factors, cytokines, mRNA, and proteins, which support the development of a tumor microenvironment and support the metastatic process. This review will discuss the different actions that platelet membranes and cancer cell membranes carry out during their relationship in the tumor microenvironment and metastasis.

18 July 2024 in RIDE Revista Iberoamericana para la Investigación y el Desarrollo Educativo
Verified
Journal Article
Open access
PDF file
RHRubén Cervantes Hernández
Rubén Cervantes Hernández
PGPerla Ivonne Gallegos-Flores
Perla Ivonne Gallegos-Flores
AEAdso Eduardo Gutiérrez Espinoza
Adso Eduardo Gutiérrez Espinoza
El Sistema Nacional de Investigadoras e Investigadores (SNII) reconoce e incentiva a investigadores, con el fin de estimular el desarrollo científico en México. Sin embargo, aún persiste una disparidad de género, en el que las mujeres son minoría, a pesar de que en los últimos años ha habido una mayor inclusión de mujeres en las diversas áreas de la ciencia. Nuestro estudio revisa la literatura que aborda esta disparidad para comprender por qué las mujeres aún son minorías en la labor científica en la Universidad Autónoma de Zacatecas. Encontramos que hay diversos factores culturales y sociales, tales como precariedades o posibles beneficios en las Instituciones de Educación Superior (IES) que motivan su ingreso al SNII y el estímulo económico y el reconocimiento social de pertenecer al SNII. Además, se encontró que la pertenencia a dicho sistema provocó en algunos casos padecimientos mentales (crisis, ansiedad, angustia y estrés, entre otros). Para superar los problemas en las IES y las afectaciones causadas al pertenecer al SNII, científicos e investigadores han buscado y aplicado diversas estrategias, entre las que destacan el apoyo psicológico profesional, conversar con allegados, apegarse a la fe, buscar atención médica, organizar tiempos y ejercicio físico. En el caso de las investigadoras, se encontró que están afectadas por límites socialmente disimulados (el hogar, la crianza y ser madres).